Clinical Trial Update: Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib

View source ↗

Summary

Real-world evaluation of patient characteristics and treatment patterns in chronic myeloid leukemia in chronic phase patients treated with asciminib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (Scemblix) (asciminib)

Snippet

Sponsor: Novartis | Conditions: Chronic Myeloid Leukemia, Chronic Phase | Status: COMPLETED